http://jcps.bjmu.edu.cn

• 研究论文 • 上一篇    下一篇

新型非肽类血管紧张素II受体拮抗剂 2. 喹唑啉酮和喹唑啉衍生物

蒋巡天, 许天林, 华维一, 朱东亚, 余静, 梁少梅   

  1. 中国药科大学新药研究中心, 南京 210009
  • 收稿日期:1998-11-18 修回日期:1999-05-04 出版日期:2000-03-15 发布日期:2000-03-15

New Non-peptide Angiotensin II Antagonists, 2. Quinazolinone and Quinazoline Derivatives

Jiang Xuntian, Xu Tianlin, Hua Weiyi, Zhu Dongya, Yu Jing, Liang Shaomei   

  1. New drugs research center,China Pharmaceutical University, Nanjing 210009
  • Received:1998-11-18 Revised:1999-05-04 Online:2000-03-15 Published:2000-03-15

摘要: 本文设计、合成了一系列喹唑啉酮(Ⅳ)和喹唑啉苯氧基苯乙酸类化合物(V), 并检测了它们的血管紧张素受体拮抗活性。前文报道了一系列喹啉苯氧基苯乙酸类非肽类血管紧张素受体拮抗剂(Ⅲ), 本文以喹唑啉酮代替化合物(Ⅲ)的喹啉获得化合物(IV), 在合成化合物(IV), 同时还获得了化合物(V)。但是这两类化合物没有进一步提高活性。在离体试验中(兔胸主动脉环), 所有的化合物均显示了竞争性拮抗活性。活性最高的喹唑啉酮(IVb)和喹唑啉(Vb)pA2值分别为7.05.9

关键词: 喹唑啉酮, 喹唑啉, 苯氧基苯乙酸, 血管紧张素II受体拮抗剂

Abstract: The design, synthesis, and angiotensin II (AII) antagonist activities of several quinazolinone (IV) and quinazoline phenoxyphenylacetic acids (V) are described. Quinazolinone ring was used to replace the quinoline moiety of quinoline phenoxyphenylacetic acids (III) which have been discovered as potent AII antagonists, to give a new series of antagonists (IV), while their quinazoline analogs (V) were obtained as isomers during the synthesis of (IV). However, both series of compounds were not found to increase the potencies. In a test for antagonizing AII in vitro using isolated rabbit aorta rings, all the compounds exerted competitive antagonism. The most potent quinazolinone (IVb) and quinazoline (Vb) had pA2 values of 7.0 and 5.9, respectively.

Key words: Quinazolinone, Quinazolinone, Quinazoline, Quinazoline, Phenoxyphenylacetic acid, Phenoxyphenylacetic acid, Angiotensin II antagonists, Angiotensin II antagonists

Supporting: 1. Current address: Department of Organic Synthesis. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200031.